XTL Biopharmaceuticals Ltd. (XTLB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2000+0.0600 (+1.91%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 3.1400 |
| Open | 3.2300 |
| Bid | 3.0000 x 800 |
| Ask | 3.3500 x 800 |
| Day's Range | 3.0700 - 3.2300 |
| 52 Week Range | 0.9200 - 6.1100 |
| Volume | 4,871 |
| Avg. Volume | 286,973 |
| Market Cap | 17.119M |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
We're sorry we weren't able to find anything about this topic.
© 2021 Verizon Media. All rights reserved.
